GCIA
KITE

Gabelli & Co Investment Advisers’s Kite Pharma, Inc. KITE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-226,276
Closed -$40.7M – 203
2017
Q3 		$40.7M Buy
+226,276
New +$31.5M 4.69% 3

Gabelli & Co Investment Advisers's KITE Position: Q4 2017 in Review

Gabelli & Co Investment Advisers sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 226,276 shares — an estimated $40.7M sold.

Gabelli & Co Investment Advisers first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $40.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Gabelli & Co Investment Advisers reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 226,276 Kite Pharma, Inc. shares in Q4 2017, an estimated $40.7M.
  • Gabelli & Co Investment Advisers first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Kite Pharma, Inc. position peaked at $40.7M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2017, filed 2 Feb 2018.